Information Library

Market Access Implementation

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • Executive Vision Forum 2010: Convergence of Stakeholders

    July 9, 2010
    A Holistic Approach to Patient Outcomes - Brian Sweet, CPO, WellPoint. Presentation about the convergence of stakeholders.

  • Executive Vision Forum 2010: Clinical and Commercial Convergence

    July 8, 2010
    Pasquale Cetera, VP Portfolio Management, Merck, presentation about the convergence of Clinical and Commercial.

  • Defining Value

    June 8, 2010
    Market Access, one of the many Consulting services available from Quintiles, stands ready to help you navigate the value substantiation process, from developing and demonstrating your product’s value platform to winning a preferred position on payer formularies and negotiating pricing and reimbursement contracts.

  • Vital Insights

    June 8, 2010
    Quintiles conducted an exhaustive analysis into global and U.S. responses to the use of comparative effectiveness research, identifying key signals to help the customer recognize risk scenarios.

  • Bridging Cultures

    May 9, 2010
    Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise.

  • Mapping the Future in Oncology Drug Development

    June 5, 2010
    Improving the development of oncology drugs is a high priority in order to enhance patient outcomes.

  • Commercial – identify, promote and prove treatment value

    April 1, 2010
    Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.

  • PharmAsia News Article Reprint

    March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

Page 1 of 1 (8 results)

Subscribe to Email Based on Your Interests

Set preferences